位置:首页 > 蛋白库 > GLUCL_DROME
GLUCL_DROME
ID   GLUCL_DROME             Reviewed;         456 AA.
AC   Q94900; O77295; Q0Q0M3; Q2PDQ5; Q59DV9; Q8IN68; Q9GQ52; Q9GQ53; Q9VDU5;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Glutamate-gated chloride channel;
DE            Short=DrosGluCl;
DE   Flags: Precursor;
GN   Name=GluClalpha; Synonyms=GluCl {ECO:0000312|EMBL:AAC47266.1};
GN   ORFNames=CG7535;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC47266.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), FUNCTION, ACTIVITY REGULATION,
RP   SUBUNIT, DEVELOPMENTAL STAGE, AND RNA EDITING OF POSITIONS 27; 241 AND 345.
RC   STRAIN=Oregon-R {ECO:0000312|EMBL:AAC47266.1};
RC   TISSUE=Head {ECO:0000312|EMBL:AAC47266.1};
RX   PubMed=8702744; DOI=10.1074/jbc.271.33.20187;
RA   Cully D.F., Paress P.S., Liu K.K., Schaeffer J.M., Arena J.P.;
RT   "Identification of a Drosophila melanogaster glutamate-gated chloride
RT   channel sensitive to the antiparasitic agent avermectin.";
RL   J. Biol. Chem. 271:20187-20191(1996).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAA05260.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), VARIANT SER-299, AND RNA EDITING OF
RP   POSITIONS 27; 63; 66 AND 241.
RC   TISSUE=Head {ECO:0000269|PubMed:9886055};
RX   PubMed=9886055; DOI=10.1046/j.1471-4159.1999.0720066.x;
RA   Semenov E.P., Pak W.L.;
RT   "Diversification of Drosophila chloride channel gene by multiple
RT   posttranscriptional mRNA modifications.";
RL   J. Neurochem. 72:66-72(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAG40735.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), NUCLEOTIDE SEQUENCE [MRNA] OF 1-336
RP   (ISOFORM B), FUNCTION, ACTIVITY REGULATION, VARIANT SER-299, AND RNA
RP   EDITING OF POSITIONS 27; 63; 66; 241 AND 345.
RX   PubMed=11095718; DOI=10.1073/pnas.240464697;
RA   Kane N.S., Hirschberg B., Qian S., Hunt D., Thomas B., Brochu R.,
RA   Ludmerer S.W., Zheng Y., Smith M., Arena J.P., Cohen C.J., Schmatz D.,
RA   Warmke J., Cully D.F.;
RT   "Drug-resistant Drosophila indicate glutamate-gated chloride channels are
RT   targets for the antiparasitics nodulisporic acid and ivermectin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:13949-13954(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM D), AND RNA EDITING OF POSITIONS 27;
RP   63; 66; 241 AND 345.
RA   Wang X., Xiang W., Wang X., Jiang L., Lin S., Gao A., Wang L., Sun L.,
RA   Jing B., Xi D.;
RT   "Cloning and functional expression of a Drosophila melanogaster glutamate-
RT   gated chloride channel.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAF55695.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND RNA EDITING OF POSITION
RP   63; 66 AND 345.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAF55695.1}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [7] {ECO:0000305}
RP   RNA EDITING OF POSITIONS 27; 63; 66; 241 AND 345.
RX   PubMed=10966106; DOI=10.1016/s0092-8674(00)00049-0;
RA   Palladino M.J., Keegan L.P., O'Connell M.A., Reenan R.A.;
RT   "A-to-I pre-mRNA editing in Drosophila is primarily involved in adult
RT   nervous system function and integrity.";
RL   Cell 102:437-449(2000).
RN   [8]
RP   FUNCTION, ACTIVITY REGULATION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE,
RP   AND MUTAGENESIS OF SER-278.
RX   PubMed=31535971; DOI=10.7554/elife.49373;
RA   Molina-Obando S., Vargas-Fique J.F., Henning M., Guer B., Schladt T.M.,
RA   Akhtar J., Berger T.K., Silies M.;
RT   "ON selectivity in the Drosophila visual system is a multisynaptic process
RT   involving both glutamatergic and GABAergic inhibition.";
RL   Elife 8:0-0(2019).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit (PubMed:11095718,
CC       PubMed:8702744). Together with Gamma-aminobutyric acid receptor Rdl,
CC       plays an important role in the visual response by regulating the
CC       activity of ON/OFF-selective neurons (PubMed:31535971).
CC       {ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:31535971,
CC       ECO:0000269|PubMed:8702744}.
CC   -!- ACTIVITY REGULATION: Glutamate binding triggers a rapidly reversible
CC       current, while the anti-helmintic drug ivermectin triggers a
CC       permanently open channel configuration (PubMed:8702744,
CC       PubMed:11095718). Inhibited by picrotoxin (PubMed:31535971).
CC       {ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:31535971,
CC       ECO:0000269|PubMed:8702744}.
CC   -!- SUBUNIT: Pentamer (By similarity). Homomultimer.
CC       {ECO:0000250|UniProtKB:G5EBR3, ECO:0000269|PubMed:8702744}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane {ECO:0000305}; Multi-
CC       pass membrane protein {ECO:0000305}. Cell membrane {ECO:0000305};
CC       Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=F;
CC         IsoId=Q94900-1; Sequence=Displayed;
CC       Name=A {ECO:0000303|PubMed:10731132};
CC         IsoId=Q94900-3; Sequence=VSP_051645;
CC       Name=B {ECO:0000269|PubMed:9886055};
CC         IsoId=Q94900-2; Sequence=VSP_051644, VSP_051646, VSP_051647;
CC       Name=C;
CC         IsoId=Q94900-4; Sequence=VSP_026113, VSP_051646, VSP_051647;
CC       Name=D;
CC         IsoId=Q94900-5; Sequence=VSP_051644, VSP_026114, VSP_051647;
CC   -!- TISSUE SPECIFICITY: Expressed in the medulla layers (at protein level)
CC       (PubMed:31535971). Expressed in all major ON pathway medulla neurons
CC       (Mi1, Tm3, Mi4, and Mi9) and in OFF pathway neurons (Tm1, Tm2, Tm4, and
CC       Tm9) (PubMed:31535971). {ECO:0000269|PubMed:31535971}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development.
CC       {ECO:0000269|PubMed:8702744}.
CC   -!- RNA EDITING: Modified_positions=27 {ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:8702744,
CC       ECO:0000269|PubMed:9886055, ECO:0000269|Ref.4}, 63
CC       {ECO:0000269|PubMed:10731132, ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:9886055,
CC       ECO:0000269|Ref.4}, 66 {ECO:0000269|PubMed:10731132,
CC       ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:9886055, ECO:0000269|Ref.4}, 241
CC       {ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744, ECO:0000269|PubMed:9886055,
CC       ECO:0000269|Ref.4}, 345 {ECO:0000269|PubMed:10731132,
CC       ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744, ECO:0000269|Ref.4}; Note=Partially edited.
CC       Edited by Adar. {ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:9886055};
CC   -!- DISRUPTION PHENOTYPE: Viable but with locomotor deficits
CC       (PubMed:31535971). Results in loss of light response in all neuronal
CC       layers part of the ON visual system (PubMed:31535971). In Mi1 neurons,
CC       does not affect function of the ON visual response (PubMed:31535971).
CC       RNAi-mediated knockdown in Mi1 or Tm3 neurons, does not affect function
CC       of the ON visual response (PubMed:31535971).
CC       {ECO:0000269|PubMed:31535971}.
CC   -!- MISCELLANEOUS: Channels desensitize rapidly in the continued presence
CC       of glutamate and are activated by the glutamate analog ibotenate. In
CC       Xenopus oocytes, avermectins and nodulisporic acid directly activate
CC       channel conductance. {ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Glutamate-gated chloride channel (TC 1.A.9.4) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U58776; AAC47266.1; -; mRNA.
DR   EMBL; AJ002232; CAA05260.1; -; mRNA.
DR   EMBL; AF297500; AAG40735.1; -; mRNA.
DR   EMBL; AF297501; AAG40736.1; -; mRNA.
DR   EMBL; DQ665648; ABG57261.1; -; mRNA.
DR   EMBL; AE014297; AAF55695.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13808.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52967.1; -; Genomic_DNA.
DR   EMBL; AE014297; ABC66182.1; -; Genomic_DNA.
DR   RefSeq; NP_001014641.2; NM_001014641.4.
DR   RefSeq; NP_001034061.2; NM_001038972.4.
DR   RefSeq; NP_650827.3; NM_142570.4.
DR   RefSeq; NP_732447.2; NM_169873.4.
DR   AlphaFoldDB; Q94900; -.
DR   SMR; Q94900; -.
DR   BioGRID; 67340; 2.
DR   STRING; 7227.FBpp0099473; -.
DR   TCDB; 1.A.9.4.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q94900; -.
DR   DNASU; 42350; -.
DR   GeneID; 42350; -.
DR   KEGG; dme:Dmel_CG7535; -.
DR   UCSC; CG7535-RA; d. melanogaster. [Q94900-1]
DR   CTD; 42350; -.
DR   FlyBase; FBgn0024963; GluClalpha.
DR   VEuPathDB; VectorBase:FBgn0024963; -.
DR   eggNOG; KOG3644; Eukaryota.
DR   InParanoid; Q94900; -.
DR   PhylomeDB; Q94900; -.
DR   Reactome; R-DME-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   BioGRID-ORCS; 42350; 0 hits in 3 CRISPR screens.
DR   GenomeRNAi; 42350; -.
DR   PRO; PR:Q94900; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   ExpressionAtlas; Q94900; baseline and differential.
DR   Genevisible; Q94900; DM.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IC:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0005231; F:excitatory extracellular ligand-gated ion channel activity; IBA:GO_Central.
DR   GO; GO:0008068; F:extracellularly glutamate-gated chloride channel activity; IDA:FlyBase.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; IBA:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0050877; P:nervous system process; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd19062; LGIC_TM_GluCl; 1.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR015680; Glu_Cl_Channel.
DR   InterPro; IPR044721; GluCl_TM.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF754; PTHR18945:SF754; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Chloride; Chloride channel;
KW   Disulfide bond; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   RNA editing; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..456
FT                   /note="Glutamate-gated chloride channel"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000000497"
FT   TOPO_DOM        23..245
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TRANSMEM        246..268
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TOPO_DOM        269..273
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TRANSMEM        274..295
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TOPO_DOM        296..302
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TRANSMEM        303..323
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TOPO_DOM        324..426
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TRANSMEM        427..450
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   TOPO_DOM        451..456
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   BINDING         71
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   BINDING         90
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   BINDING         154
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   BINDING         183
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   DISULFID        163..177
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   DISULFID        222..233
FT                   /evidence="ECO:0000250|UniProtKB:G5EBR3"
FT   VAR_SEQ         60..79
FT                   /note="GPAIVRINLFVRSIMTISDI -> NKATNVSVNMFLRSISKIDDY (in
FT                   isoform C)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_026113"
FT   VAR_SEQ         68..80
FT                   /note="LFVRSIMTISDIK -> IFVRSISKIDDVT (in isoform B and
FT                   isoform D)"
FT                   /evidence="ECO:0000303|PubMed:11095718,
FT                   ECO:0000303|PubMed:9886055, ECO:0000303|Ref.4"
FT                   /id="VSP_051644"
FT   VAR_SEQ         230..232
FT                   /note="EYS -> T (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:10731132"
FT                   /id="VSP_051645"
FT   VAR_SEQ         335..341
FT                   /note="GSNKANM -> DV (in isoform D)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_026114"
FT   VAR_SEQ         417..420
FT                   /note="Missing (in isoform B and isoform C)"
FT                   /evidence="ECO:0000303|PubMed:11095718,
FT                   ECO:0000303|PubMed:9886055"
FT                   /id="VSP_051646"
FT   VAR_SEQ         456
FT                   /note="E -> ETF (in isoform B, isoform C and isoform D)"
FT                   /evidence="ECO:0000303|PubMed:11095718,
FT                   ECO:0000303|PubMed:9886055, ECO:0000303|Ref.4"
FT                   /id="VSP_051647"
FT   VARIANT         27
FT                   /note="I -> V (in RNA edited version)"
FT                   /evidence="ECO:0000269|PubMed:10966106,
FT                   ECO:0000269|PubMed:9886055"
FT   VARIANT         63
FT                   /note="I -> V (in RNA edited version)"
FT                   /evidence="ECO:0000269|PubMed:10966106"
FT   VARIANT         66
FT                   /note="I -> V (in RNA edited version)"
FT                   /evidence="ECO:0000269|PubMed:10966106"
FT   VARIANT         241
FT                   /note="K -> R (in RNA edited version)"
FT                   /evidence="ECO:0000269|PubMed:10966106,
FT                   ECO:0000269|PubMed:9886055"
FT   VARIANT         299
FT                   /note="P -> S (resistant to nodulisporic acid)"
FT                   /evidence="ECO:0000269|PubMed:11095718,
FT                   ECO:0000269|PubMed:9886055"
FT   VARIANT         345
FT                   /note="S -> N (in RNA edited version)"
FT                   /evidence="ECO:0000269|PubMed:10966106,
FT                   ECO:0000269|PubMed:9886055"
FT   MUTAGEN         278
FT                   /note="S->T: Shows resistance to picrotoxin-induced
FT                   activity inhibition."
FT                   /evidence="ECO:0000269|PubMed:31535971"
FT   CONFLICT        50
FT                   /note="I -> V (in Ref. 4; ABG57261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="P -> S (in Ref. 3; AAG40736)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379
FT                   /note="V -> A (in Ref. 4; ABG57261)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   456 AA;  52307 MW;  AE892B338B79A060 CRC64;
     MGSGHYFWAI LYFASLCSAS LANNAKINFR EKEKKVLDQI LGAGKYDARI RPSGINGTDG
     PAIVRINLFV RSIMTISDIK MEYSVQLTFR EQWTDERLKF DDIQGRLKYL TLTEANRVWM
     PDLFFSNEKE GHFHNIIMPN VYIRIFPNGS VLYSIRISLT LACPMNLKLY PLDRQICSLR
     MASYGWTTND LVFLWKEGDP VQVVKNLHLP RFTLEKFLTD YCNSKTNTGE YSCLKVDLLF
     KREFSYYLIQ IYIPCCMLVI VSWVSFWLDQ GAVPARVSLG VTTLLTMATQ TSGINASLPP
     VSYTKAIDVW TGVCLTFVFG ALLEFALVNY ASRSGSNKAN MHKESMKKKR RDLEQASLDA
     ASDLLDTDSN ATFAMKPLVR HPGDPLALEK RLQCEVHMQA PKRPNCCKTW LSKFPTRQCS
     RSKRIDVISR ITFPLVFALF NLVYWSTYLF REEEDE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024